0.298
price down icon13.14%   -0.0451
pre-market  시장 영업 전:  .29   -0.008   -2.68%
loading
전일 마감가:
$0.3431
열려 있는:
$0.3028
하루 거래량:
3.09M
Relative Volume:
10.66
시가총액:
$13.94M
수익:
-
순이익/손실:
$-52.53M
주가수익비율:
-0.0814
EPS:
-3.66
순현금흐름:
$-39.93M
1주 성능:
-62.20%
1개월 성능:
-58.40%
6개월 성능:
-73.86%
1년 성능:
-77.25%
1일 변동 폭
Value
$0.27
$0.3393
1주일 범위
Value
$0.241
$0.8215
52주 변동 폭
Value
$0.241
$3.10

Unity Biotechnology Inc Stock (UBX) Company Profile

Name
명칭
Unity Biotechnology Inc
Name
전화
(650) 416-1192
Name
주소
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Name
직원
16
Name
트위터
@unitybiotech
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
UBX's Discussions on Twitter

UBX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
UBX
Unity Biotechnology Inc
0.298 13.94M 0 -52.53M -39.93M -3.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-27 다운그레이드 H.C. Wainwright Buy → Neutral
2025-05-16 다운그레이드 Mizuho Outperform → Neutral
2024-08-22 개시 Rodman & Renshaw Buy
2023-11-16 업그레이드 Wedbush Neutral → Outperform
2022-01-04 업그레이드 ROTH Capital Neutral → Buy
2021-11-10 업그레이드 Mizuho Neutral → Buy
2021-06-28 업그레이드 Citigroup Sell → Buy
2021-06-07 개시 H.C. Wainwright Buy
2021-02-16 다운그레이드 Citigroup Neutral → Sell
2020-08-18 다운그레이드 Citigroup Buy → Neutral
2020-08-18 다운그레이드 Mizuho Buy → Neutral
2020-08-18 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-08-17 다운그레이드 ROTH Capital Buy → Neutral
2020-07-28 개시 ROTH Capital Buy
2019-12-12 개시 Cantor Fitzgerald Overweight
2019-03-07 개시 Cantor Fitzgerald Overweight
2018-09-07 개시 Mizuho Buy
2018-05-29 개시 Citigroup Buy
2018-05-29 개시 Goldman Neutral
2018-05-29 개시 Morgan Stanley Overweight
모두보기

Unity Biotechnology Inc 주식(UBX)의 최신 뉴스

pulisher
Jun 14, 2025

Biotech company once valued at $700 million slashes entire workforce - MSN

Jun 14, 2025
pulisher
Jun 12, 2025

Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech

Jun 12, 2025
pulisher
May 30, 2025

HC Wainwright Issues Optimistic Forecast for UBX Earnings - Defense World

May 30, 2025
pulisher
May 29, 2025

Unity Biotechnology stock hits 52-week low at $0.66 - Investing.com

May 29, 2025
pulisher
May 29, 2025

Unity Biotechnology stock hits 52-week low at $0.66 By Investing.com - Investing.com India

May 29, 2025
pulisher
May 28, 2025

HC Wainwright & Co. Downgrades Unity Biotechnology (LSE:0YC0) - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Unity Biotechnology (NASDAQ:UBX) Receives Neutral Rating from HC Wainwright - Defense World

May 28, 2025
pulisher
May 27, 2025

Unity Biotech stock rating downgraded at H.C. Wainwright By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday - Benzinga

May 27, 2025
pulisher
May 27, 2025

Unity Biotechnology (UBX) Downgraded Amid Strategic Shifts | UBX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

HC Wainwright Downgrades Unity Biotechnology to Neutral From Buy, Adjusts Price Target to $2 From $4 - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Unity Biotechnology (UBX) Downgrade: HC Wainwright & Co. Cuts Pr - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Unity Biotech stock rating downgraded at H.C. Wainwright - Investing.com

May 27, 2025
pulisher
May 27, 2025

Unity Biotechnology (UBX) Downgrade: HC Wainwright & Co. Cuts Price Target | UBX Stock News - GuruFocus

May 27, 2025
pulisher
May 21, 2025

Jeff Bezos-backed, lifespan-focused Altos Labs buys small biotech with Stanford rootsSan Francisco Business Times - The Business Journals

May 21, 2025
pulisher
May 18, 2025

Unity Biotechnology (NASDAQ:UBX) Rating Lowered to “Neutral” at Mizuho - Defense World

May 18, 2025
pulisher
May 17, 2025

Mizuho cuts Unity Biotech stock rating, slashes price target to $1 - Investing.com Nigeria

May 17, 2025
pulisher
May 16, 2025

Mizuho Downgrades Unity Biotechnology to Neutral From Outperform After Diabetic Edema Treatment Misses Primary Endpoint, Cuts Price Target to $1 From $6 - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Unity Biotechnology (UBX) Downgraded Amid Trials and Strategic N - GuruFocus

May 16, 2025
pulisher
May 11, 2025

Unity Biotechnology (UBX) to Release Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 10, 2025

Bay Area biotech company Unity, once worth $700M, lays off entire remaining workforce - MSN

May 10, 2025
pulisher
May 09, 2025

'It's a mess out there': More biotech layoffs mean stiff competition for jobs at emerging companies - The Business Journals

May 09, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Sells 16,759 Shares of Unity Biotechnology, Inc. (NASDAQ:UBX) - Defense World

May 08, 2025
pulisher
May 07, 2025

Another Bay Area biotech company announces layoffs - MSN

May 07, 2025
pulisher
May 06, 2025

Bluebird pleads for deal support; Unity, Mersana lay off staff - BioPharma Dive

May 06, 2025
pulisher
May 05, 2025

Bay Area biotech company lays off every single worker, including CEO - SFGATE

May 05, 2025
pulisher
May 05, 2025

Finance Watch: Unity Lays Off All Employees As It Evaluates Alternatives - insights.citeline.com

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology (UBX) Reports Promising 36-Week Results from ASPIRE Trial | UBX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Unity Biotechnology Explores Strategic Alternatives Post-ASPIRE Study - TipRanks

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates - The Manila Times

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Announces Complete 36-Week Results from - GlobeNewswire

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of - Bluefield Daily Telegraph

May 05, 2025
pulisher
May 05, 2025

UNITY's New DME Treatment Rivals Aflibercept in Phase 2b Trial, Company Explores Strategic Options - Stock Titan

May 05, 2025
pulisher
May 01, 2025

UNITY Biotechnology to Present 36-Week Data from ASPIRE Phase 2B Study at ARVO 2025 Annual Meeting - Nasdaq

May 01, 2025
pulisher
May 01, 2025

UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting - The Manila Times

May 01, 2025
pulisher
Apr 29, 2025

UNITY Biotechnology tanks after failing to meet goal in eye disorder treatment trial - MSN

Apr 29, 2025
pulisher
Apr 28, 2025

Chardan Capital Brokers Decrease Earnings Estimates for UBX - Defense World

Apr 28, 2025
pulisher
Apr 26, 2025

Form 8-KCurrent report - ADVFN

Apr 26, 2025
pulisher
Apr 26, 2025

HC Wainwright Issues Positive Outlook for UBX Earnings - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

HC Wainwright Reiterates “Buy” Rating for Unity Biotechnology (NASDAQ:UBX) - Defense World

Apr 25, 2025
pulisher
Apr 25, 2025

Chardan Capital Reaffirms “Buy” Rating for Unity Biotechnology (NASDAQ:UBX) - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

Unity Biotechnology Reports Q1 2025 Financials and Study Updates - TipRanks

Apr 24, 2025
pulisher
Apr 23, 2025

H.C. Wainwright maintains $4 target on Unity Biotech stock - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Unity Biotechnology (UBX) Reports $16.9M in Cash, Prepares for F - GuruFocus

Apr 23, 2025

Unity Biotechnology Inc (UBX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):